BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 29187452)

  • 21. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
    J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
    Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
    Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
    Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGFβ/activin signaling pathway activation in intimal hyperplasia and atherosclerosis.
    Oklü R; Hesketh R; Wicky S; Metcalfe J
    Diagn Interv Radiol; 2011 Sep; 17(3):290-6. PubMed ID: 20954112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of Smad2 activity shows resistance to TGF-β signalling in mammary adenocarcinoma (MCF-7) cells.
    Sengupta S; Kundu S; Bhattacharyya A
    Cell Biol Int; 2013 May; 37(5):449-57. PubMed ID: 23494890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor.
    Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H
    J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells.
    Choi JH; Hwang YP; Kim HG; Khanal T; Do MT; Jin SW; Han HJ; Lee HS; Lee YC; Chung YC; Jeong TC; Jeong HG
    Nutr Cancer; 2014; 66(1):140-51. PubMed ID: 24341702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells.
    Castellana B; Aasen T; Moreno-Bueno G; Dunn SE; Ramón y Cajal S
    Oncotarget; 2015 Nov; 6(35):38239-56. PubMed ID: 26512918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
    Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW
    J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
    Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GATA-2 inhibits transforming growth factor-β signaling pathway through interaction with Smad4.
    Dong XM; Yin RH; Yang Y; Feng ZW; Ning HM; Dong L; Zheng WW; Tang LJ; Wang J; Jia YX; Jiang YN; Liu ED; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Yang XM
    Cell Signal; 2014 May; 26(5):1089-97. PubMed ID: 24509415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Y-box protein-1 controls transforming growth factor-beta1 translation in proximal tubular cells.
    Fraser DJ; Phillips AO; Zhang X; van Roeyen CR; Muehlenberg P; En-Nia A; Mertens PR
    Kidney Int; 2008 Mar; 73(6):724-32. PubMed ID: 18075498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutual regulation between Raf/MEK/ERK signaling and Y-box-binding protein-1 promotes prostate cancer progression.
    Imada K; Shiota M; Kohashi K; Kuroiwa K; Song Y; Sugimoto M; Naito S; Oda Y
    Clin Cancer Res; 2013 Sep; 19(17):4638-50. PubMed ID: 23838318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of the transforming growth factor-β pathway by tolfenamic acid via the ERK MAP kinase pathway.
    Zhang X; Min KW; Liggett J; Baek SJ
    Carcinogenesis; 2013 Dec; 34(12):2900-7. PubMed ID: 23864386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.
    Astanehe A; Finkbeiner MR; Hojabrpour P; To K; Fotovati A; Shadeo A; Stratford AL; Lam WL; Berquin IM; Duronio V; Dunn SE
    Oncogene; 2009 Jun; 28(25):2406-18. PubMed ID: 19430491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of JNK enhances TGF-beta1-activated Smad2 signaling in mouse embryonic lung.
    Wu S; Kasisomayajula K; Peng J; Bancalari E
    Pediatr Res; 2009 Apr; 65(4):381-6. PubMed ID: 19127219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels.
    Huang W; Rubinstein J; Prieto AR; Wang DH
    J Hypertens; 2010 Feb; 28(2):367-76. PubMed ID: 19887954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.